Sevinç Odabaşı Güneş

Sevinç Odabaşı Güneş

Auto-generated profile, based on publicly available information

Sevinç Odabaşı Güneş

Department of Pediatric Endocrinology, UHS Gulhane Training and Research Hospital, Ankara, Turkiye

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
EÖElif Özsu
Elif Özsu
SÇSemra Çağlar Çetinkaya
Semra Çağlar Çetinkaya
SBSemih Bolu
Semih Bolu
NHNihal Hatipoglu
Nihal Hatipoglu
ŞEŞenay Savaş Erdeve
Şenay Savaş Erdeve
ZAZehra Aycan
Zehra Aycan
Maturity-onset diabetes of the young (MODY) occurs due to mutations in genes involved in pancreatic beta cell function and insulin secretion, has heterogeneous clinical and laboratory features, and account for 1-5% of all diabetes cases. The prevalence and distribution of MODY subtypes vary between countries. The aim of this study was to evaluate the clinical and laboratory characteristics, mutation distribution, and phenotype-genotype relationship in a large case series of pediatric Turkish patients genetically diagnosed with MODY. MODY cases from 14 different pediatric endocrinology departments were included. Diagnosis, treatment, follow-up data, and results of genetic analysis were evaluated. A total of 224 patients were included, of whom 101 (45%) were female, and the mean age at diagnosis was 9.4±4.1 years. Gene variant distribution was: 146 (65%) GCK; 43 (19%) HNF1A; 8 (3.6%) HNF4A, 8 (3.6%) KLF11 and 7 (3.1%) HNF1B. The remaining 12 variants were: PDX (n=1), NEUROD1 (n=3), CEL (n=1), INS (n=3), ABCC8 (n=3) and KJNC11 (n=1). Of the cases, 197 (87.9%) were diagnosed with incidental hyperglycemia, 16 with ketosis (7%) and 7 (3%) with diabetic ketoacidosis (DKA), while 30% presented with classical symptoms of diabetes. Two-hundred (89%) had a family history of diabetes. Anti-GAD antibody was detected in 13 cases, anti-islet antibody in eight and anti-insulin antibody in four. Obesity was present in 16. Distribution of therapy was: 158 (71%) diet only; 23 (11%) intensive insulin treatment; 17 (7.6%) sulfonylureas; 10 (4.5%) metformin; and 6 (2.7%) insulin and oral antidiabetic treatment. This was the largest genetically diagnosed series from Turkey. The most common gene variants were GCK and HNF1A with much lower proportions for other MODY types. Hyperglycemia was the most common presenting symptom while 11% of patients had diabetes-associated autoantibodies and 7% were obese. The majority of patients received dietary management only.

23 December 2024 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
SGSevinç Odabaşı Güneş
Sevinç Odabaşı Güneş
IKİlknur Kaba
İlknur Kaba
EÜEdip Ünal
Edip Ünal
ABAyşe Derya Buluş
Ayşe Derya Buluş
İDİsmail Dündar
İsmail Dündar
ZSZeynep Siklar
Zeynep Siklar
Journal of Clinical Research in Pediatric Endocrinology

23 December 2024 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
IKİlknur Kaba
İlknur Kaba
EÜEdip Ünal
Edip Ünal
İDİsmail Dündar
İsmail Dündar
ABAyşe Derya Buluş
Ayşe Derya Buluş
SGSevinç Odabaşı Güneş
Sevinç Odabaşı Güneş
ZSZeynep Siklar
Zeynep Siklar
Journal of Clinical Research in Pediatric Endocrinology

1 December 2021 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
PDF file
MMMina Mısırlıgil
Mina Mısırlıgil
YYYILMAZ YILDIZ
YILMAZ YILDIZ
OAOnur Akın
Onur Akın
SGSevinç Odabaşı Güneş
Sevinç Odabaşı Güneş
MAMutluay Arslan
Mutluay Arslan
BÜBülent Ünay
Bülent Ünay
Kabuki syndrome (KS) is a disease characterized by distinctive facial features, skeletal anomalies and delay in neuromotor development. KS 1 is an autosomal dominant condition caused by mutations in the KMT2D gene, whereas KS 2 is an X-linked disorder caused by mutations in the KDM6A gene. In the majority of KS patients who present with hypoglycemia, KDM6A is the defective gene. A 9-month old girl was admitted to our emergency department due to a seizure. On physical examination, hypotonia, mild facial dysmorphism, brachydactyly of the 5th finger, prominent finger pads and pansystolic murmur were detected. A fasting glucose tolerance test was performed the next day due to her history of hypoglycemia, but she had convulsions at the fifth hour of the test. Her serum glucose was 24 mg/dL, insulin 1.94 mIU/L, C-peptide 0.94 ng/mL, growth hormone 11 ng/mL, anti-insulin antibody 4.2 IU/mL, cortisol 19.8 mu g/dL, and adrenocorticotropic hormone 9.3 pg/mL. A diagnosis of hyperinsulinemic hypoglycemia was considered. Given the abnormalities, genetic analysis for congenital hyperinsulinism, including the genes causing KS was performed. A heterozygous frameshift mutation (c.2579del, p.Leu860Argfs*70) was detected in the KMT2D gene. Epilepsy and other neurological symptoms may be seen in KS patients and in some of these the neurological symptoms are the result of hypoglycemia. In such cases, the detection and prevention of hypoglycemia can help prevent the progression of neurological symptoms. We suggest considering the diagnosis of KS for patients with hypoglycemia and dysmorphic features, even if the patient does not manifest all features of KS.

1 August 2022 in Güncel Pediatri
Verified
Journal Article
Closed access
ETEsra Tunçer
Esra Tunçer
AKAlev Keser
Alev Keser
EÜEmine Nüket Ünsal
Emine Nüket Ünsal
SGSevinç Odabaşı Güneş
Sevinç Odabaşı Güneş
OAOnur Akın
Onur Akın

27 May 2020 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
SGSevinc Odabasi Gunes
Sevinc Odabasi Gunes
AEAyca Torel Ergur
Ayca Torel Ergur
FKFatma Nisanci Kilinc
Fatma Nisanci Kilinc